Reasons for bullish bias: - Safe entry at LH breakout - Price bounce from support - Bullish divergence - Positive Earnings Here are the recommended trading levels: Entry Level(Buy stop): 68.59 Stop Loss Level: 64.05 Take Profit Level 1: 71.98 Take Profit Level 2: 84.79 Take Profit Level 3: Open
Reasons for bullish bias: - Bounce from strong support - Bullish engulfing candle formed at weekly closing Entry Level(CMP): 75.58 Stop Loss Level: 71.20 Take Profit Level 1: 79.96 Take Profit Level 2: 84.34 Take Profit Level 3: Open
If you haven`t bought GILD before the previous earnings: Then analyzing the options chain and the chart patterns of GILD Gilead Sciences prior to the earnings report this week, I would consider purchasing the 80usd strike price Calls with an expiration date of 2024-6-21, for a premium of approximately $3.10. If these options prove to be profitable prior to the...
In a recent announcement, Gilead Sciences ( NASDAQ:GILD ) disclosed disappointing results from a late-stage trial evaluating its antibody-drug conjugate, Trodelvy, in second-line treatment for advanced non-small cell lung cancer (NSCLC). The Phase 3 study, aiming to expand Trodelvy's applications, did not meet its primary goal of significantly improving survival...
from Ebola treatment to quick remedy for Corona truly a mission worth funding and risking on
If you haven`t bought GILD on the Remdesivir approval: Then analyzing the options chain and the chart patterns of GILD Gilead Sciences prior to the earnings report this week, I would consider purchasing the 80usd strike price in the money Calls with an expiration date of 2024-1-19, for a premium of approximately $4.25. If these options prove to be profitable...
XABCD, ABC patterns at play. Confirmation via eMA, candlestick pattern. Here we go. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Confirmation level, where relevant, is a pink dotted, finite line. Fibonacci goals, it is...
Indeed. B Wave in a zigzag form appears to be completed. We are going down to one extent to another. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Confirmation level, where relevant, is a pink dotted, finite line....
Looks like the base is formed and a reversal is on track. Target 1&2 - Dotted lines.
GILD - The Sleeping Giant - Trend Reversal ___________________ ENTRY = 56.56 Double Bottom - +64 confirmation 1st Target = .236fib@72.33 2nd Target = .382fib@82.08 3rd Target = .5fib@89.97 HOLD Target = .618@97.85+ JAN22 Call Leaps Still...
I dislike Pharma as much as I dislike manipulation but GILD bounced off .618 fib and I like it. Seems like a $65-70 stock trading at a discount. Solid 4.8% DIV yield in addition. Dont forget these folks also have anti Rona stuff so it could all come together.
Gilead activated a double bottom pattern with target at $104.6, +84% from current price. This structure would be inactivated below $55.80 so the stop loss would be around that zone. The risk/reward ratio is 45.
I dislike trading pharma BUT I like GILD
EN: Gilead Sciences, Inc. is an American biopharmaceutical company based in Foster City, California, that researches, develops and markets drugs in under-explored areas of medical need in the United States, Europe, and internationally. Its products include treatments for human immunodeficiency virus (HIV) infection and liver disease. It is currently...
FDA provides preliminary approval for the drug filgotinib not approved, Galapagos will now assume full responsibility for filgotinib in Europe. Gilead will pay EUR 160 million to Galapagos to accelerate commercial activities in Europe. The gap from 19 march 2019 is filled....ready for the turn up..... what do you think?
I like this chart a lot actually. if we bounce off this crossroad, we will reach the moon eventually. Adding a little to my long position. Have a terrific weekend!
Wonderful bullish news! There is a vaccine. The economic activity can soon go back to normal. The question now is how do we make it obligatory? Crazy antivax conspiracy theorists are saying that because it is a rushed & untested vaccine and entirely new technology that affects ARN and contains heavy metals that can breach the blood-brain barrier we should let...
Reuters Adage Capital Partners GP LLC Dissolves Share Stake In Moderna, Takes In Gilead Sciences! Reuters: Germany requests 5% of EU supply of remdesivir Germany has requested around 5% of the supply of remdesivir under a six-month European Union supply deal, its health ministry said on Monday, despite criticism of the deal due to a lack of evidence about the...